期刊文献+

新生后给药地塞米松对大鼠肺形态发育的影响

Effects of postnatal dexamethasone on rat lung morphogenesis
下载PDF
导出
摘要 目的:比较生后给予不同剂量地塞米松(dexamethasone,DEX)对大鼠肺组织形态发育的影响。方法:120只新生大鼠随机平均分为3组。小剂量DEX组:生后第5天起连续5天腹腔注射DEX0.2mg/(kg·d)。大剂量DEX组:生后第5天起连续5天腹腔注射DEX0.5mg/(kg·d)。生理盐水组:生后第5天起连续5天腹腔注射等量生理盐水。各组大鼠分别在生后第10、14、21、45天随机选取10只处死,分离肺组织,通过光镜观察,分析比较各组用药对肺形态发育的影响。结果:两DEX治疗组在生后各时间点每视野肺泡计数均低于生理盐水组(P﹤0.01),平均肺泡表面积均高于生理盐水组(P﹤0.05)。两DEX治疗组平均肺泡间隔厚度在生后第10、14天均低于生理盐水组(P﹤0.01),在生后第21天均高于生理盐水组(P﹤0.05)。结论:生后给DEX能显著促进肺部早期发育,但随着给药剂量的增多,肺泡化受阻现象逐渐明显,最终导致肺泡大而少的"气肿样"改变出现,其影响可持续至成年。 Objective:To compare the effects of different dosage of dexamethasone (DEX) on rat lung morphogenesis. Methods: Total of 120 newborn rats were divided into three groups randomly:a small dosage DEX group,a large dosage DEX group and a control group. On the 10th,14th,21st,45th days after birth,the histologic structures of 10 rat lungs in each group were observed with light microscope. Results:Under the light microscope,during the first 2 weeks,rat lungs in the two treatment groups had fewer alveolar numbers,larger alveolar space,and thinner alveolar septum compared with those in the control group (P〈0.01). On the 21st and 45th days,the airspaces of rat lungs in the two treatment groups were still enlarged,while the alveolar spetums were thickening. An "emphysematous"condition of the lungs could be observed especially in the large dosage DEX group. Conclusion:Using DEX postnatal could promote lung morphogenesis obviously,while with the dose increased,the normal alveolization was inhibited,and the impact continued well into adulthood.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第3期366-370,共5页 Journal of Nanjing Medical University(Natural Sciences)
关键词 地塞米松 形态发育 dexamethasone lung morphogenesis
  • 相关文献

参考文献15

  • 1Mestan KK, Marks JD, Hecox K, et al. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide [J]. N Engl J Med, 2005,353( 1):23-32.
  • 2Vrijlandt E J, Gerritsen J, Boezen HM, et al. Gender differences in respiratory symptoms in 19-year-old adults born preterm[J]. Respir Res, 2005,6:117.
  • 3Grier DG,Halliday HL Management of bronchopulmonary dysplasia in infants:guidelines for corticosteroid use [J]. Drugs, 2005,65 ( 1 ) : 15-29.
  • 4Mataloun MM, Leone CR, Gibelli MA, et al. Effects of corticosteroids in very low birth weight newborns dependent on mechanical ventilation[J]. Clinics,2005,60(2), 113- 120.
  • 5Yeh TF,Lin Y J, Lin HC,et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity [J]. N Engl J Med,2004,350 (13):1304- 1313.
  • 6Doyle LW,Davis PG, Morley CJ,et al. Low-dose dexamethasone facilitates extubation among chronically ventila- tor-dependent infants:a muhicenter,international,randomized, controlled trial [ J ]. Pediatrics, 2006,117 ( 1 ) : 75-83.
  • 7朱翠平,马祖祥.地塞米松对早产儿支气管肺发育不良预防作用的荟萃分析[J].广东医学,2006,27(3):415-418. 被引量:7
  • 8Powell K, Kerkering KW, Barker G, et al. Dexamethasone dosing,mechanical ventilation and the risk of cerebral palsy[J]. J Matern Fetal Neonatal Med,2006,19(1):43- 48.
  • 9Parikh NA,Lasky RE,Kennedy KA,et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants[J]. Pediatrics,2007,119 (2) :265-272.
  • 10Fayon M,Jouvencel P, Caries D,et al. Differential effect of dexamethasone and hydrocortisone on alveolar growth in rat pups[ J ]. Pediatr Pulmonol, 2002,33 (6) : 443-448.

二级参考文献12

  • 1SHORT E J,KLEIN N K,LEWIS B A,et al.Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight:8-year-old outcomes[J].Pediatrics,2003,112:e359.
  • 2SMITH J.An update on bronchopulmonary dysplasia:is there a relationship to the development of childhood asthma[J].Med Hypotheses,2003,61:495-502.
  • 3GARLAND J S,ALEX C P,PAULY T H,et al.A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates:A randomized trial[J].Pedistrics,1999,104(1 Pt 1):91 -99.
  • 4ROMAGNOLI C,ZECCA E,LUCIANO R,et al.Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants:a 3-year follow-up[J].Pediatrics,2002,109(6):e85.
  • 5SINKIN R A,DWECK H S,HORGAN M J,et al.Early dexamethasone-attempting to prevent chronic lung disease[J].Pediatrics,2000,105(3 Pt 1):542-548.
  • 6Vermont Oxford Network Steroid Study Group.Early postnatal dexamethasone therapy for the prevention of chronic lung disease[J].Pediatrics,2001,108(3):741-748.
  • 7TAPIA J L,RAMIREZ R,CIFUENTES J,et al.The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome[J].J Pediatr,1998,132(1):48-52.
  • 8RASTOGI A,AKINTORIN S M,BEZ M L,et al.A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant -treated infants[J].Pediatrics,1996,98(2 Pt 1):204-210.
  • 9DURAND M,SARDESAI S,McEVOY C.Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants:a randomized,controlled trial[J].Pediatrics,1995,95(4):584-590.
  • 10ROMAGNOLI C,ZECCAE,VENTO G,et al.Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants[J].Intensive Care Med,1999,25(7):717-721.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部